Iván Gutiérrez-Aranda

Enrichment of Human ESC-Derived Multipotent Mesenchymal Stem Cells with Immunosuppressive and Anti-Inflammatory Properties Capable to Protect Against Experimental Inflammatory Bowel Disease

Laura Sánchez, Iván Gutiérrez-Aranda, Gertrudis Ligero et al. · Stem Cells · 2010 · 138 citations

Cell Therapy, Adult Stem Cell, Immunology +20

The Nodal inhibitor Lefty is negatively modulated by the microRNA miR‐302 in human embryonic stem cells

Alicia Barroso‐delJesus, Gema Lucena-Aguilar, Laura Sánchez et al. · The FASEB Journal · 2011 · 102 citations

Deficiency in p53 but not Retinoblastoma Induces the Transformation of Mesenchymal Stem Cells <i>In vitro</i> and Initiates Leiomyosarcoma <i>In vivo</i>

Ruth Rubio, Javier Garcı́a-Castro, Iván Gutiérrez-Aranda et al. · Cancer Research · 2010 · 97 citations

Adult Stem Cell, Cell Proliferation, Stem Cell Biology +18

The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development

Ruth Rubio, Iván Gutiérrez-Aranda, Ana I. Sáez-Castillo et al. · Oncogene · 2012 · 93 citations · Full text

Vivo Sarcoma Development, Developmental Biology, Differentiation Stage +6

Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia

Rosa Montes, Verónica Ayllón, Iván Gutiérrez-Aranda et al. · Blood · 2011 · 88 citations · Full text